Research Digest Cannabis Clinical Studies March 2026
This research digest cannabis clinical studies March 2026 compiles 40 recent peer-reviewed studies curated for clinical relevance and evidence quality. It highlights key findings from cannabis clinical research and evidence reviews. Stay informed with…
Synergistic Neuroimmune Modulation by Cannabidiol and Probiotics for Therapeutic Advancement in CNS Disorders
This systematic review explores gut-brain axis cannabidiol probiotics synergy for neuroimmune modulation in CNS disorders. It highlights emerging evidence on combined CBD and probiotic effects. The review underscores the need for clinical validation of…
Modulating the Endocannabinoid System in Alcohol Use Disorder: A Translational Review
Modulating endocannabinoid system alcohol use disorder is a promising area of research with significant preclinical evidence. This review synthesizes data on cannabinoid receptor modulation and its impact on alcohol consumption. Understanding these…
Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder: A Translational Systematic Review and Meta-Analysis
Cannabis co-use tobacco cessation presents unique challenges in treating tobacco use disorder. This review highlights how cannabis use affects quit success rates. Understanding endocannabinoid system modulation is key to advancing treatment strategies.
Preclinical Evidence of Cannabis-Induced Oxidative Stress: Systematic Review & Meta-Analysis
Cannabis oxidative stress markers are critical in understanding cellular damage linked to cannabis exposure. This systematic review evaluates reactive oxygen species and lipid peroxidation in preclinical models. Findings highlight oxidative stress…
Millions Use Marijuana to Cope with Anxiety and Depression, But a Major New Study Says It …
A comprehensive review of cannabis for anxiety and depression reveals insufficient evidence supporting its use for these conditions. Millions use cannabis for symptom relief, but clinical trials show limited efficacy. Potential risks include worsening…
Challenges in Cannabis Mental Health Treatment: Evidence and Review
This review highlights cannabis mental health treatment challenges due to limited and inconsistent evidence. Clinicians should be cautious when considering cannabis for mental health conditions. Understanding these challenges helps inform evidence-based…
Cannabinoids for Mental, Substance Use Disorders ‘Rarely Justified,’ Study Suggests
This article reviews cannabinoid clinical trials mental disorders evidence indicating limited efficacy for mental health and substance use disorders. The findings suggest cannabinoids offer minimal benefit for cannabis withdrawal and no advantage over…
Major Review Finds Limited Benefit of Cannabis-Based Treatments for Psychiatric Conditions
A comprehensive review of cannabis-based treatments psychiatric conditions found minimal to no significant clinical benefit. This evidence highlights the limited efficacy of cannabis in psychiatric care. Clinicians should consider these findings when…
Lancet Reveals Key Findings on Medicinal Cannabis and Mental Health
This cannabinoid safety and efficacy mental health study offers clinicians crucial evidence for prescribing medicinal cannabis in psychiatric conditions. The Lancet review synthesizes scattered data to inform safer clinical decisions. It highlights both…
